The sample size of 30 patients in each group was required to achieve a power of 90% with alpha = 0.05 to detect a medium to large effect size of 0.86 in post-operative troponin I level
Unfortunately, there is no direct evidence indicated the hyperglucagonemia after bariatric surgery yet, but higher glucagon release within the first 2 h and higher trend of peak level of glucagon in post RYGB patients when compared to SG or neither operation group has been recently reported (Svane et al., 2019)
The FDA gave no objection to GRAS application GRN No
For this reason, patients who have had, or have family members who have ever had medullary thyroid carcinoma should not use liraglutide, nor should patients who have an endocrine system condition called multiple endocrine neoplasia syndrome type 2
Not all insurance formularies cover the obesity versions yet, and coverage for diabetes may require step therapy (e.g
Proceedings (Baylor University Medical Center), 27 (4), 321-324